Alligator Bioscience
0.566
SEK
+12.52 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 following
+12.52%
-17.97%
-55.15%
-56.19%
-36.55%
-17.85%
+33.65%
-58.31%
-91.26%
-97.21%
alligatorbioscience.se/investerare
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Revenue
58.11M
EBIT %
-428.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ATORX
Daily low / high price
0.48 / 0.57
SEK
Market cap
429.59M SEK
Turnover
1.21M SEK
Volume
2.4M
Latest videos
Financial calendar
Annual report
2025-02-13
Interim report
2025-04-24
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Allegro Investment | 32.9 % | 33.0 % |
| Roxette Photo | 8.6 % | 8.6 % |
| Magnus Petersson | 2.8 % | 2.8 % |
| Avanza Pension | 2.8 % | 2.8 % |
| Nordnet Pension Insurance | 2.4 % | 2.4 % |
| Johan Zetterstedt | 2.2 % | 2.2 % |
| Handelsbanken Funds | 1.8 % | 1.8 % |
| Lars Spånberg | 1.3 % | 1.3 % |
| Harri Salminen | 0.7 % | 0.7 % |
| Zetterstedt Holding AB | 0.7 % | 0.7 % |
ShowingAll content types
Alligator announces sale of future financial commitments for two bispecific antibodies to Orion Corporation
ALG.APV-527, en bispecifik First-in-Class antikropp, når viktiga mål i fas 1-studie i solida tumörer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools